SCHEMBL2565595

SCHEMBL2565595

CN1Cc2ccccc2-n2c(nnc2C2CCC(c3cccc(Cl)n3)CC2)C1

nearest known ligand 0.57

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
AVPR1A P37288 20/20 0.57
KCNH2 Q12809 3/20 0.50
AVPR2 P30518 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2546439 0.89 AVPR1A (0.61) AVPR1AKCNH2AVPR2
SCHEMBL2546438 0.89 AVPR1A (0.61) AVPR1AKCNH2AVPR2
SCHEMBL2565369 0.85 AVPR1A (0.55) AVPR1AKCNH2AVPR2
SCHEMBL2558789 0.85 AVPR1A (0.55) AVPR1AKCNH2AVPR2
SCHEMBL2565826 0.82 AVPR1A (0.56) AVPR1AKCNH2AVPR2
SCHEMBL2544865 0.80 AVPR1A (0.61) AVPR1AKCNH2AVPR2
SCHEMBL2544864 0.80 AVPR1A (0.61) AVPR1AKCNH2AVPR2
SCHEMBL2545499 0.79 AVPR1A (0.60) AVPR1AKCNH2AVPR2
SCHEMBL2545503 0.79 AVPR1A (0.60) AVPR1AKCNH2AVPR2
SCHEMBL2563310 0.78 AVPR1A (0.64) AVPR1AKCNH2AVPR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP claimed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO claimed
EP-2560975-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. Hoffmann-La Roche AG (CH) 2013-02-27 EP disclosed
WO-2011131596-A1 HETEROARYL-CYCLOHEXYL-TETRAAZABENZO[E]AZULENES AS VASOPRESSIN V1A RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2011-10-27 WO disclosed